跳至主要内容
临床试验/NCT05872308
NCT05872308已完成不适用

Hemorrhagic Myocardial Infarction Detection With High-sensitivity Cardiac Troponin-I

Rohan Dharmakumar2 个研究点 分布在 2 个国家目标入组 227 人开始时间: 2022年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
227
试验地点
2
主要终点
Diagnostic Threshold

研究概览

简要总结

Pilot trial to determine diagnostic efficacy of post-reperfusion troponin kinetics in detection of hemorrhagic myocardial infarction

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Index STEMI
  • Coronary angiogram with PCI to occur irrespective of the onset of the symptoms.
  • Ability to provide informed consent for themselves

排除标准

  • History of prior myocardial infarction,
  • Cardiogenic shock,
  • Patients who present with current cardiac arrest
  • Any contraindication to cardiac CMR (claustrophobia, pacemaker or cardiac defibrillator, known allergy to gadolinium),
  • Presence of permanent atrial fibrillation,
  • Unconscious patient,
  • Severe renal insufficiency (creatinine clearance ≤ 30 ml/min/m2 or renal replacement therapy),
  • Women who are pregnant or breastfeeding. Women of reproductive potential must have a negative pregnancy test.

结局指标

主要结局

Diagnostic Threshold

时间窗: 48 hours

Levels of markers in hemorrhagic infarct vs. non-hemorrhagic infarct

次要结局

  • Peak levels of serum troponin-I(48 hours)
  • Hemorrhagic infarct microvascular obstruction(48 hours)
  • Area under the curve (AUC) for serum troponin-I(48 hours)
  • Hemorrhagic infarct volume(48 hours)
  • Hemorrhagic infarct area at risk(48 hours)
  • Hemorrhagic infarct size(48 hours)

研究者

申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rohan Dharmakumar

Vice Chair of Research, Medical Imaging Research Institute

Indiana University School of Medicine

研究点 (2)

Loading locations...

相似试验